Fundz

Watching DarioHealth Corp.? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNegative

DarioHealth Corp.

www.dariohealth.com
Filed: Jul 10, 2026NEW YORK, New YorkCIK: 0001533998Biotechnology
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

DarioHealth Corp. announced on July 10, 2026, that Steven Nelson's temporary medical leave of absence as President and Chief Commercial Officer has been extended indefinitely, with his responsibilities to be assumed by the senior management team. This leadership transition raises concerns about operational continuity and strategic decision-making.

Key Takeaways

Steven Nelson's medical leave has been extended indefinitely, creating uncertainty about his return timeline

Senior management team will assume Nelson's responsibilities as President and Chief Commercial Officer during his absence

2 more takeaways

Related Filings (1)

1 more filing from DarioHealth Corp. in the last 90 days

Filing Overview

Form Type8-K
Filing DateJul 10, 2026
Item5.02
CategoryExecutive Change
CIK0001533998
Risk LevelMEDIUM
SentimentNegative
Signalrisk
Topics
leadership transitionexecutive departure

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings